Cognex Corporation
CGNX
$65.63
+6.56%
Cognex Corporation is a leading provider of machine vision products, including vision software, systems, sensors, and ID readers, that automate manufacturing processes across industries such as automotive, electronics, and logistics. As a market leader in industrial machine vision, Cognex differentiates itself through its proprietary vision algorithms and deep integration with robotics and automation, serving a global customer base with a strong presence in the United States and Europe. The current investor narrative centers on the company's robust recovery from a cyclical downturn, driven by a rebound in factory automation spending, the adoption of AI-enhanced vision solutions, and a recent surge in share price following strong quarterly results and positive analyst sentiment. However, debates persist regarding the sustainability of growth amid macroeconomic uncertainty and the company's ability to maintain its premium valuation.…
CGNX
Cognex Corporation
$65.63
CGNX 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cognex Corporation's 12-month outlook, with a consensus price target around $80.05 and implied upside of +22.0% versus the current price.
Average Target
$80.05
0 analysts
Implied Upside
+22.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$65 - $92
Analyst target range
The target price range spans from a low of $62.00 to a high of $94.00, representing a wide spread of 51.6% from the low to the high, which signals considerable uncertainty about the company's future performance. The low target of $62.00 suggests that some analysts see limited downside, possibly pricing in a slowdown in automation spending or margin compression, while the high target of $94.00 implies a scenario of accelerating growth and multiple expansion, likely driven by AI-driven demand and market share gains. The recent upgrade from JP Morgan and the overall bullish consensus indicate that analysts are becoming more optimistic, but the wide range highlights the risk that the stock's premium valuation may be vulnerable to disappointment.
Drowning in data?
Find the real signal!
Bulls vs Bears: CGNX Investment Factors
Cognex presents a compelling growth story with accelerating revenue, expanding margins, and a strong balance sheet, but the stock's premium valuation and cyclical end-markets introduce significant risk. The bull case is currently stronger, driven by the inflection in revenue growth and AI-driven demand, but the high PE and PEG ratios leave little room for error. The key tension is whether the company can sustain its 20%+ growth trajectory to justify the valuation, or if a slowdown in automation spending will trigger a de-rating. Investors should monitor quarterly order trends and margin sustainability closely.
Bullish
- Revenue Growth Accelerating: Q1 2026 revenue surged 24.3% YoY to $268.4M, a sharp acceleration from 9.8% growth in Q4 2025, signaling a robust recovery in factory automation spending. This marks the third consecutive quarter of sequential revenue growth, from $216.0M in Q1 2025 to $268.4M in Q1 2026.
- Strong Gross Margin Expansion: Gross margin improved to 71.1% in Q1 2026, up from 65.7% in Q4 2025 and above the 66.9% trailing average, reflecting favorable product mix and operating leverage. This margin expansion is driving earnings growth faster than revenue.
- Analyst Consensus is Buy: With a mean recommendation of 1.75 (Buy) and an average target price of $77.21, analysts see 18.3% upside from the current price of $65.24. The recent JP Morgan upgrade and bullish sentiment underscore improving fundamentals.
- Healthy Balance Sheet: Debt-to-equity is a mere 0.05, and the current ratio stands at 3.80, indicating ample liquidity and minimal financial risk. This financial strength supports continued investment in R&D and potential acquisitions.
Bearish
- Premium Valuation Limits Upside: The trailing PE of 52.9x and forward PE of 36.6x are well above the market average, and the PEG ratio of 5.5x suggests the stock is priced for perfection. Any earnings miss could trigger a sharp de-rating.
- High Beta and Volatility: With a beta of 1.49, the stock is significantly more volatile than the market, as evidenced by a -28.0% max drawdown over the past year. This makes it susceptible to macro-driven selloffs.
- Cyclicality of Factory Automation: Revenue is highly dependent on capital spending by manufacturers, which is cyclical. The recent recovery could stall if global industrial production weakens, as seen in the 2024 downturn when revenue stagnated.
- Wide Analyst Target Range: The analyst target range spans from $62.00 to $94.00, a 51.6% spread, indicating significant uncertainty about future performance. The low target implies a potential 5% downside from current levels.
CGNX Technical Analysis
Cognex's stock has demonstrated a powerful uptrend over the past year, with a 1-year price change of +60.02%, significantly outperforming the S&P 500's +18.19%. The current price of $65.24 sits near the upper end of its 52-week range, at approximately 89.5% of the distance from the 52-week low of $34.60 to the high of $72.88, indicating strong momentum and investor confidence. This positioning near the highs suggests the market is rewarding the company's growth trajectory, though it also raises concerns about potential overextension and vulnerability to profit-taking.
Beta
1.50
1.50x market volatility
Max Drawdown
-28.0%
Largest decline past year
52-Week Range
$35-$73
Price range past year
Annual Return
+50.8%
Cumulative gain past year
| Period | CGNX Return | S&P 500 |
|---|---|---|
| 1m | +3.8% | +2.9% |
| 3m | +2.1% | +5.0% |
| 6m | +11.6% | +13.9% |
| 1y | +50.8% | +20.4% |
| ytd | +77.7% | +13.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CGNX Fundamental Analysis
Cognex's revenue trajectory has turned decisively upward, with the most recent quarter (Q1 2026) reporting revenue of $268.4 million, a 24.3% year-over-year increase, accelerating from the prior quarter's 9.8% growth. This marks a clear inflection from the stagnant or declining revenue seen in 2024 and early 2025, driven by robust demand for standard products and services, which contributed $254.4 million of the total, while application-specific solutions added $14.0 million. The multi-quarter trend shows sequential improvement, with revenue rising from $216.0 million in Q1 2025 to $249.1 million in Q2 2025, $276.9 million in Q3 2025, and $252.3 million in Q4 2025, before the strong Q1 2026 print, indicating a sustained recovery in factory automation spending.
Quarterly Revenue
$268437000.0B
2026-04
Revenue YoY Growth
+24.3%
YoY Comparison
Gross Margin
71.1%
Latest Quarter
Free Cash Flow
$241106000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CGNX Overvalued?
Given Cognex's positive net income, the PE ratio is the most appropriate valuation metric. The trailing PE stands at 52.9x, while the forward PE is 36.6x, implying the market expects significant earnings growth over the next year. The gap between trailing and forward multiples suggests that analysts anticipate a substantial improvement in profitability, likely driven by revenue growth and operating leverage. The PEG ratio of 5.5x, however, indicates that the stock is priced at a premium to its expected earnings growth rate, which may limit upside potential.
PE
52.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 32x~104x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include the company's reliance on continued revenue growth to justify its high valuation, with a trailing PE of 52.9x and forward PE of 36.6x. While debt is minimal (D/E of 0.05), the payout ratio of 47.7% and modest dividend yield of 0.9% indicate limited income support. Operating margin of 16.3% is respectable but could compress if revenue growth decelerates, as seen in 2024 when margins dipped. The company's cash flow generation is solid (FCF TTM of $241M), but any downturn in orders could pressure cash conversion.
